Logo MOH
  • About Us
    About National Pharmacy Strategy About National Drug Formulary List of Abbreviations NDF User Guide NDF User Stories
  • About Drugs
    NDF A to Z Listing NDF Listing by Pharmacological Classification
  • FAQs
  • Useful Resources
    ACE Technology Guidances ACE Clinical Guidances (ACGs) MOH Guidelines for all Healthcare Professionals MOH Medication Safety MOH List of Subsidised Drugs MOH Know Your Meds Series MOH Subsidised Vaccines List MOH Healthcare Schemes & Subsidies MOH Cancer Drug List National Immunisation Schedules Healthhub Glossary of Medications Rare Disease Fund (KKH website)
    Drug-related Legislations
      Health Products Act Health Products (Therapeutic Products) Regulations Misuse of Drug Act
    COVID-19 Updates
MOH
  1. Home
  2. Monograph
A- A+

Monograph

Subsidy Information and Financing Scheme

Not Applicable

Drug Guidance for Subsidy

Not Applicable

Post Marketing Information

PEM 19/05/2025 ULTOMIRIS® (ravulizumab): Guide for Healthcare Professionals

PMG 19/05/2025 ULTOMIRIS® (ravulizumab): Guide for Patients/Parents/Caregivers

PAC 19/05/2025 ULTOMIRIS® PATIENT CARD: Important Safety Information for Patients Taking ULTOMIRIS® (ravulizumab)

List of monographs containing this active ingredient

Ravulizumab [Ultomiris]
22 Dec 2022

National Drug Formulary (NDF)

About Us
  • About National Pharmacy Strategy
  • About National Drug Formulary
  • List of Abbreviations
  • User Guide
  • User Stories
  • FAQs
About Drugs
  • Search for Drugs
  • NDF A to Z Listing
  • NDF Listing by Pharmacological Classification
Useful Resources
  • ACE Technology Guidances
  • ACE Clinical Guidances (ACGs)
  • MOH Guidelines for all Healthcare Professionals
  • MOH Medication Safety
  • MOH List of Subsidised Drugs
  • MOH Know Your Meds Series
  • MOH Subsidised Vaccines List
  • MOH Healthcare Schemes & Subsidies
  • MOH Cancer Drug List
  • National Immunisation Schedules
  • Healthhub Glossary of Medications
  • Rare Disease Fund (KKH website)  
  • Drugs-related Legislations
    • Health Products Act
    • Health Products (Therapeutic Products) Regulations
    • Misuse of Drug Act
  • COVID-19 Updates
Quicklinks
  • HSA Infosearch
  • HSA Report Adverse Events
  • Healthcare Professional Portal
  • Synapxe SDD Lite
  • Listing of Licensed Healthcare Institutions
    • Public Hospitals
    • Polyclinics 
  • Report Vulnerability
  • Privacy Policy
  • Terms of Use
  • Contact Us     
© 2021 National Drug Formulary (NDF)
Last Updated on 01 October 2025